Article Text
Editor’s column
Neurointervention: a call to science
Statistics from Altmetric.com
Footnotes
Contributors MJG solely responsible for the content.
Competing interests MJG has been a consultant on a fee-per-hour basis for Codman Neurovascular, InNeuroCo, Medtronic Neurovascular and Stryker Neurovascular; holds stock in InNeuroCo; and has received research support from the National Institutes of Health (NIH), Anaconda, CereVasc LLC, Codman Neurovascular, Gentuity, Microvention, Medtronic Neurovascular, Neuravi, Philips Healthcare, InNeuroCo, R92M, Rapid Medical, The Stroke Project, Stryker Neurovascular, and the Wyss Institute.
Provenance and peer review Commissioned; internally peer reviewed.